Publications
Here you can browse the complete list of publications for studies listed on CDAS.
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. | 25044253 | Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y | Urol. Oncol. | 2014 | NLST, PLCO |
| Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. | 24979231 | McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ | PLoS ONE | 2014 | NLST |
| CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases. | 24955929 | Yip R, Henschke CI, Yankelevitz DF, Smith JP | Radiology | 2014 | NLST |
| Impact of lung cancer screening results on smoking cessation. | 24872540 | Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL | J. Natl. Cancer Inst. | 2014 | NLST |
| Short- and long-term lung cancer risk associated with noncalcified nodules observed on low-dose CT. | 24755313 | Pinsky PF, Nath PH, Gierada DS, Sonavane S, Szabo E | Cancer Prev Res (Phila) | 2014 | NLST |
| Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. | 24577803 | Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, Hazelton WD, Plevritis SK | Cancer | 2014 | NLST, PLCO |
| Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. | 24379002 | de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammemägi MC, Hazelton WD, Feuer EJ, McMahon PM | Ann. Intern. Med. | 2014 | NLST |
| A qualitative study of lung cancer risk perceptions and smoking beliefs among national lung screening trial participants. | 23999653 | Park ER, Streck JM, Gareen IF, Ostroff JS, Hyland KA, Rigotti NA, Pajolek H, Nichter M | Nicotine Tob. Res. | 2014 | NLST |
| Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. | 25460915 | Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD | PLoS Med. | 2014 | NLST, PLCO |
| Cost-effectiveness of CT screening in the National Lung Screening Trial. | 25372087 | Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C, National Lung Screening Trial Research Team | N. Engl. J. Med. | 2014 | NLST |
| Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. | 25326638 | Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR | J. Natl. Cancer Inst. | 2014 | NLST |
| Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis. | 25217774 | Bodelon C, Pfeiffer RM, Buys SS, Black A, Sherman ME | J. Natl. Cancer Inst. | 2014 | PLCO |
| Abnormal CA-125 levels in menopausal women without ovarian cancer. | 25127988 | Terada KY, Elia J, Kim R, Carney M, Ahn HJ | Gynecol. Oncol. | 2014 | PLCO |
| Interval lung cancers not detected on screening chest X-rays: How are they different? | 25123333 | Kvale PA, Johnson CC, Tammemägi M, Marcus PM, Zylak CJ, Spizarny DL, Hocking W, Oken M, Commins J, Ragard L, Hu P, Berg C, Prorok P | Lung Cancer | 2014 | PLCO |
| Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | 25038532 | Marcus PM, Ogden SL, Gren LH, Childs JC, Pretzel SM, Lamerato LE, Walsh K, Rozjabek HM, Mabie J, Thomas B, Riley T | Prev Med | 2014 | PLCO |
| Diabetes and pancreatic cancer survival: a prospective cohort-based study. | 24786605 | Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G | Br. J. Cancer | 2014 | PLCO |
| Modified Gleason grade of prostatic adenocarcinomas detected in the PLCO cancer screening trial. | 24594407 | Humphrey PA, Hickey TP, Riley TL, Mabie JE, Bellinger A, Strother M, Andriole GL | J. Urol. | 2014 | PLCO |
| Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. | 24718282 | Olson SH, Hsu M, Wiemels JL, Bracci PM, Zhou M, Patoka J, Reisacher WR, Wang J, Kurtz RC, Silverman DT, Stolzenberg-Solomon RZ | Cancer Epidemiol. Biomarkers Prev. | 2014 | PLCO |
| Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. | 23982929 | Ryan BM, Zanetti KA, Robles AI, Schetter AJ, Goodman J, Hayes RB, Huang WY, Gunter MJ, Yeager M, Burdette L, Berndt SI, Harris CC | Int. J. Cancer | 2014 | PLCO |
| A prospective study of serum metabolites and colorectal cancer risk. | 24894841 | Cross AJ, Moore SC, Boca S, Huang WY, Xiong X, Stolzenberg-Solomon R, Sinha R, Sampson JN | Cancer | 2014 | PLCO |